Use Mirolut is used to prevent the development of gastric ulcers associated with NSAID use in patients at increased risk of ulceration, as well as to treat exacerbations of duodenal ulcers and gastric ulcers. In combination with mifepristone, Mirolut is used for early pregnancy termination (up to 42 days of amenorrhea). How to take Mirolut is taken orally. A single dose is 200-400 mcg; for increased sensitivity and renal insufficiency, it is 100 mcg. The frequency of administration and duration of use depend on the indications and treatment effectiveness. For pregnancy termination in combination with mifepristone, the drug is prescribed at 400 mcg (2 tablets) 36-48 hours after taking 600 mg (3 tablets) of mifepristone. Use for pregnancy termination should only be carried out in specialized institutions with qualified personnel. Contraindications Mirolut is contraindicated in: - Hypersensitivity to the components of the drug. - Pregnancy (except for cases of pregnancy termination) and breastfeeding. - Liver and kidney diseases. - Cardiovascular diseases. - Diseases associated with prostaglandin dependence or contraindications to the use of prostaglandins, such as glaucoma, bronchial asthma, arterial hypertension. - Endocrinopathies and endocrine system diseases, including diabetes mellitus and adrenal dysfunction. - Hormone-dependent tumors. - Anemia. Use of intrauterine contraceptives (IUD must be removed before use). - Suspicion of ectopic pregnancy. - Childhood. Storage Store in a dry, dark place, at a temperature not exceeding 25 degreeC. Keep out of reach of children.